May Measurement Month 2022: an analysis of blood pressure screening results from Mexico

2022年5月测量月:墨西哥血压筛查结果分析

阅读:2

Abstract

The May Measurement Month (MMM) campaign was carried out in Mexico in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at first-contact health centres in several states of the Mexican Republic. Three seated BP readings were taken for each participant, along with the completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 41 953 adults were screened, with a mean age of 48.5 years and 58.2% were female. Of all participants, 16 888 (40.3%) had hypertension, of whom 14 465 (85.7%) were aware, and 14 265 (84.5%) were on antihypertensive medication. Of those on antihypertensive medication, 9712 (68.1%) had controlled BP, and of all participants with hypertension, 57.5% had controlled BP. In total, 7176 (17.1%) had either untreated or inadequately treated hypertension. In conclusion, the MMM campaign in Mexico in 2022 identified significant numbers of participants with either untreated or inadequately treated hypertension. Among those on antihypertensive medication, only two-thirds of them achieved controlled BP levels, despite receiving their medication at no direct cost to them, suggesting a significant problem of medical inertia.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。